Madison Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Madison Asset Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.57M	Sell	5,729 -55	-1%	-$37.4K	0.04%	207
2026 Q1	$4.47M	Sell	5,784 -185	-3%	-$142K	0.06%	173
2025 Q4	$4.61M	Sell	5,969 -142	-2%	-$96.4K	0.05%	177
2025 Q3	$3.44M	Sell	6,111 -290	-5%	-$164K	0.04%	191
2025 Q2	$3.36M	Sell	6,401 -19	-0.3%	-$10.6K	0.04%	197
2025 Q1	$4.07M	Sell	6,420 -25	-0.4%	-$17.2K	0.05%	178
2024 Q4	$4.59M	Sell	6,445 -114	-2%	-$95.7K	0.05%	173
2024 Q3	$6.9M	Sell	6,559 -1,069	-14%	-$1.19M	0.08%	153
2024 Q2	$8.02M	Sell	7,628 -163	-2%	-$158K	0.1%	142
2024 Q1	$7.5M	Sell	7,791 -499	-6%	-$474K	0.09%	149
2023 Q4	$7.28M	Sell	8,290 -103	-1%	-$84.8K	0.1%	149
2023 Q3	$6.91M	Sell	8,393 -134	-2%	-$105K	0.1%	150
2023 Q2	$6.13M	Sell	8,527 -31	-0.4%	-$23.9K	0.09%	151
2023 Q1	$7.03M	Sell	8,558 -51	-0.6%	-$38.5K	0.11%	145
2022 Q4	$6.21M	Sell	8,609 -91	-1%	-$67.1K	0.1%	149
2022 Q3	$5.99M	Sell	8,700 -18	-0.2%	-$11.3K	0.1%	142
2022 Q2	$5.15M	Buy	+8,718	New	+$5.67M	0.08%	161

Other funds holding REGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Madison Asset Management's REGN Position: Q2 2026 in Review

Madison Asset Management reduced its Regeneron Pharmaceuticals (REGN) stake by 0.95% in Q2 2026, selling an estimated $37.4K and leaving 5,729 shares worth $3.57M. The position accounts for 0.04% of the portfolio, ranked #207.

Madison Asset Management first reported a position in REGN in Q2 2022 and has held it in 17 quarters since. The position peaked at $8.02M in Q2 2024. 1,340 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Madison Asset Management held 5,729 shares of Regeneron Pharmaceuticals worth $3.57M as of Q2 2026.
Madison Asset Management sold 55 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $37.4K.
Regeneron Pharmaceuticals made up 0.04% of Madison Asset Management's portfolio in Q2 2026, its #207 holding.
Madison Asset Management first reported a position in Regeneron Pharmaceuticals in Q2 2022 and has held it in 17 quarters since.
Madison Asset Management's Regeneron Pharmaceuticals position peaked at $8.02M in Q2 2024.
1,340 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Madison Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.